Carolina Molecular and Astoriom announced a strategic partnership to provide seamless, integrated solutions for molecular testing and comprehensive biospecimen storage.
This collaboration addresses a critical unmet need for Contract Research Organizations (CROs), pharmaceutical and biotechnology partners by offering a streamlined workflow from sample receipt and storage through advanced molecular analysis.
The partnership combines Carolina Molecular's expertise in CAP/CLIA-certified and NYS-registered molecular testing, including NGS Foundry services and bioinformatic analysis, with Astoriom's extensive capabilities in ICH-compliant stability storage, CAP-certified biorepository and ultra-low and cryogenic temperature solutions across the US, EU, and UK. Clients will benefit from a collaborative solution for sample management and molecular testing needs, ensuring sample integrity, regulatory compliance, and accelerated research and development timelines.
For further information, please visit: https://www.astoriom.com/our-solutions.
Visit Astoriom for more news
